An estimated 251 million people around the world are living with COPD.1 This places a heavy social and economic burden on individuals, communities and our global healthcare system.
ResMed works with respiratory physicians, healthcare systems and insurers to develop innovative solutions that can be used to effectively manage and monitor COPD patients at home.

Treatment gaps and unmet patient priorities in COPD


People with COPD have to cope with a lack of disease knowledge2,3, under-diagnosis4, impaired QoL5 and hospitalisations6, along with other unmet needs.


COPD symptoms can have a significant effect on a person’s quality of life.8-10 Symptoms can limit their ability to perform everyday tasks and can cause depression. 8-10 It’s important to address these issues in order to improve patient outcomes.

Learn about home high-flow therapy for COPD

Learn when home high flow therapy can be indicated for domiciliary use in COPD patients experiencing secretion management issues.

Discover key findings from recent clinical research into the mechanism of action of home high-flow therapy and its clinical outcomes in patients with COPD

Learn about home NIV for COPD

Home NIV for Chronic Obstructive Pulmonary Disease (COPD)

Learn more about why, when and how to prescribe home non-invasive ventilation (NIV) for COPD.

Research in home NIV for COPD

Discover key findings from recent clinical research and their implications for treatment decision-making and patient selection.

The expert’s voice

Interview, Dr Chris Carlin

Can automatic modes and telemonitoring support and simplify NIV pathways and good quality care in COPD and OHS?

Interview, Pr Gonzalez-Bermejo

How to reconcile with high-intensity NIV in home COPD patients.

All the news,
all in one place

Have you visited our new clinical news page?
Don’t miss out on the latest respiratory research articles and news.

Non-contractual image of a nasal cannula – only use nasal cannulas recommended by ResMed


  1. World Health Organization. (accessed January 31, 2019)
  2. Baiardini I, Rogliani P, Santus P, Corsico AG, Contoli M, Scichilone N, Di Marco F, Lessi P, Scognamillo C, Molinengo G, Ferri F, Patella V, Fiorentino G, Carone M, Braido F. Disease awareness in patients with COPD: measurement and extent. Int J Chron Obstruct Pulmon Dis. 2019;14:1–11. doi: 10.2147/COPD.S179784
  3. Nakken N, Janssen DJA, van den Bogaart EHA, Muris JWM, Vercoulen JH, Custers FL, Bootsma GP, Gronenschild MHM, Wouters EFM, Spruit MA. Knowledge gaps in patients with COPD and their proxies. BMC Pulm Med. 2017;17:136. doi: 10.1186/s12890-017-0481-8
  4. Ho T, Cusack RP, Chaudhary N, Satia I, Kurmi OP. Under- and over-diagnosis of COPD: a global perspective. Breathe (Sheff). 2019 Mar;15(1):24-35. doi: 10.1183/20734735.0346-2018
  5. Franssen FME, Smid DE, Deeg DJH, Huisman M, Poppelaars J, Wouters EFM, Spruitet MA. The physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam. NPJ Prim Care Respir Med. 2018;28(1):30. doi:10.1038/s41533-018-0097-3
  6. Yeatts KB, Lippmann SJ, Waller AE, Hassmiller Lich K, Travers D, Weinberger M, Donohue JF. Population-based burden of COPD-related visits in the ED, return ED visits, hospital admissions, and comorbidity risks. Chest. 2013;144:784–93
  7. Svedsater H et al. Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups. Adv Ther 2017;34(6):1466-1481
  8. Doward L et al. Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes. NPJ Prim Care Respir Med. 2017;27:66
  9. Cook NS et al. Patients’ perspectives on COPD: findings from a social media listening study. ERJ Open Res. 2019;5(1):00128-2018